Published in EMBO J on March 17, 1997
Estrogen receptor interaction with estrogen response elements. Nucleic Acids Res (2001) 4.23
Steroid-induced androgen receptor-oestradiol receptor beta-Src complex triggers prostate cancer cell proliferation. EMBO J (2000) 2.96
Emergence of constitutively active estrogen receptor-α mutations in pretreated advanced estrogen receptor-positive breast cancer. Clin Cancer Res (2014) 2.92
The AF1 and AF2 domains of the androgen receptor interact with distinct regions of SRC1. Mol Cell Biol (1999) 2.00
Ligand-independent recruitment of steroid receptor coactivators to estrogen receptor by cyclin D1. Genes Dev (1998) 1.97
Loss of ERbeta expression as a common step in estrogen-dependent tumor progression. Endocr Relat Cancer (2004) 1.84
Estrogen receptor transcription and transactivation: Estrogen receptor alpha and estrogen receptor beta: regulation by selective estrogen receptor modulators and importance in breast cancer. Breast Cancer Res (2000) 1.69
Phosphorylation of human estrogen receptor alpha by protein kinase A regulates dimerization. Mol Cell Biol (1999) 1.60
Probing protein conformational changes in living cells by using designer binding proteins: application to the estrogen receptor. Proc Natl Acad Sci U S A (2002) 1.40
A mutation mimicking ligand-induced conformational change yields a constitutive RXR that senses allosteric effects in heterodimers. EMBO J (1997) 1.30
Classical estrogen receptor alpha signaling mediates negative and positive feedback on gonadotropin-releasing hormone neuron firing. Endocrinology (2008) 1.22
Activation of androgen receptor function by a novel nuclear protein kinase. Mol Biol Cell (1998) 1.13
CIA, a novel estrogen receptor coactivator with a bifunctional nuclear receptor interacting determinant. Mol Cell Biol (2001) 1.04
Characterization of the DNA-binding and dimerization properties of the nuclear orphan receptor germ cell nuclear factor. Mol Cell Biol (1999) 0.95
Estrogen receptor α in cancer-associated fibroblasts suppresses prostate cancer invasion via modulation of thrombospondin 2 and matrix metalloproteinase 3. Carcinogenesis (2013) 0.92
Survey of phosphorylation near drug binding sites in the Protein Data Bank (PDB) and their effects. Proteins (2014) 0.88
Vestigialization of an allosteric switch: genetic and structural mechanisms for the evolution of constitutive activity in a steroid hormone receptor. PLoS Genet (2014) 0.83
Unliganded estrogen receptor alpha promotes PC12 survival during serum starvation. PLoS One (2013) 0.82
Heat shock protein 90 and the nuclear transport of progesterone receptor. Cell Stress Chaperones (2001) 0.79
Development of a novel molecular sensor for imaging estrogen receptor-coactivator protein-protein interactions. PLoS One (2012) 0.78
Molecular Mechanisms of Transcription Activation by Juvenile Hormone: A Critical Role for bHLH-PAS and Nuclear Receptor Proteins. Insects (2012) 0.77
Genomic modelling of the ESR1 Y537S mutation for evaluating function and new therapeutic approaches for metastatic breast cancer. Oncogene (2016) 0.76
High-efficiency transformation of mammalian cells by plasmid DNA. Mol Cell Biol (1987) 43.61
The nuclear receptor superfamily: the second decade. Cell (1995) 24.99
A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell (1996) 11.02
Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Science (1995) 10.42
A versatile in vivo and in vitro eukaryotic expression vector for protein engineering. Nucleic Acids Res (1988) 7.28
Steroid hormone receptors: many actors in search of a plot. Cell (1995) 7.22
Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase. Science (1995) 6.37
The human estrogen receptor has two independent nonacidic transcriptional activation functions. Cell (1989) 6.24
Crystal structure of the ligand-binding domain of the human nuclear receptor RXR-alpha. Nature (1995) 5.40
Crystal structure of the RAR-gamma ligand-binding domain bound to all-trans retinoic acid. Nature (1995) 4.79
ER beta: identification and characterization of a novel human estrogen receptor. FEBS Lett (1996) 4.77
The N-terminal part of TIF1, a putative mediator of the ligand-dependent activation function (AF-2) of nuclear receptors, is fused to B-raf in the oncogenic protein T18. EMBO J (1995) 4.72
A canonical structure for the ligand-binding domain of nuclear receptors. Nat Struct Biol (1996) 4.69
Identification of a conserved region required for hormone dependent transcriptional activation by steroid hormone receptors. EMBO J (1992) 4.69
A nonchromatographic assay for expression of the chloramphenicol acetyltransferase gene in eucaryotic cells. Anal Biochem (1986) 4.60
A structural role for hormone in the thyroid hormone receptor. Nature (1995) 4.27
Nuclear factor RIP140 modulates transcriptional activation by the estrogen receptor. EMBO J (1995) 4.23
Environmentally persistent alkylphenolic compounds are estrogenic. Endocrinology (1994) 4.10
Role of the protein chaperone YDJ1 in establishing Hsp90-mediated signal transduction pathways. Science (1995) 3.91
Polarity-specific activities of retinoic acid receptors determined by a co-repressor. Nature (1995) 3.90
Tyrosine kinase/p21ras/MAP-kinase pathway activation by estradiol-receptor complex in MCF-7 cells. EMBO J (1996) 3.59
Activation of the unliganded estrogen receptor by EGF involves the MAP kinase pathway and direct phosphorylation. EMBO J (1996) 3.53
The nuclear hormone receptor coactivator SRC-1 is a specific target of p300. Proc Natl Acad Sci U S A (1996) 3.43
Characterization and colocalization of steroid binding and dimerization activities in the mouse estrogen receptor. Cell (1990) 3.37
Interaction of proteins with transcriptionally active estrogen receptors. Proc Natl Acad Sci U S A (1994) 3.10
HER-2 tyrosine kinase pathway targets estrogen receptor and promotes hormone-independent growth in human breast cancer cells. Oncogene (1995) 2.84
Characterization of the ligand-dependent transactivation domain of thyroid hormone receptor. EMBO J (1994) 2.62
Differential ligand-dependent interactions between the AF-2 activating domain of nuclear receptors and the putative transcriptional intermediary factors mSUG1 and TIF1. EMBO J (1996) 2.47
CREB binding protein acts synergistically with steroid receptor coactivator-1 to enhance steroid receptor-dependent transcription. Proc Natl Acad Sci U S A (1996) 2.41
Estrogen action via the cAMP signaling pathway: stimulation of adenylate cyclase and cAMP-regulated gene transcription. Proc Natl Acad Sci U S A (1994) 2.41
Dopaminergic and ligand-independent activation of steroid hormone receptors. Science (1991) 2.33
Phosphorylation of the human estrogen receptor. Identification of hormone-regulated sites and examination of their influence on transcriptional activity. J Biol Chem (1994) 2.30
Inhibition of estrogen receptor-DNA binding by the "pure" antiestrogen ICI 164,384 appears to be mediated by impaired receptor dimerization. Proc Natl Acad Sci U S A (1990) 2.03
Hold 'em and fold 'em: chaperones and signal transduction. Science (1995) 1.74
Stimulation of estrogen receptor-mediated transcription and alteration in the phosphorylation state of the rat uterine estrogen receptor by estrogen, cyclic adenosine monophosphate, and insulin-like growth factor-I. Mol Endocrinol (1993) 1.56
A conserved C-terminal sequence that is deleted in v-ErbA is essential for the biological activities of c-ErbA (the thyroid hormone receptor). Mol Cell Biol (1993) 1.52
Hormone-dependent transactivation by the human androgen receptor is regulated by a dnaJ protein. J Biol Chem (1995) 1.39
Steroid and related receptors. Curr Opin Cell Biol (1993) 1.34
Modulation of the ligand-independent activation of the human estrogen receptor by hormone and antihormone. Proc Natl Acad Sci U S A (1993) 1.30
Collagen-induced morphogenesis and expression of the alpha 2-integrin subunit is inhibited in c-erbB2-transfected human mammary epithelial cells. Oncogene (1993) 1.29
Retinoic acid receptor-beta: immunodetection and phosphorylation on tyrosine residues. Mol Endocrinol (1992) 1.16
Phosphorylation of tyrosine 537 on the human estrogen receptor is required for binding to an estrogen response element. J Biol Chem (1995) 1.13
Phosphorylation stimulates the transcriptional activity of the human beta 1 thyroid hormone nuclear receptor. Proc Natl Acad Sci U S A (1992) 1.10
Nuclear receptors spring into action. Nat Struct Biol (1996) 1.08
Peptide growth factor cross-talk with the estrogen receptor requires the A/B domain and occurs independently of protein kinase C or estradiol. Endocrinology (1996) 1.06
In vivo and in vitro phosphorylation of the human estrogen receptor. J Steroid Biochem Mol Biol (1995) 1.00
Characterization of ligand-dependent phosphorylation of the estrogen receptor. Mol Endocrinol (1994) 1.00
Identification of phosphorylation sites in the mouse oestrogen receptor. J Steroid Biochem Mol Biol (1995) 0.89
Oestradiol stimulates tyrosine phosphorylation and hormone binding activity of its own receptor in a cell-free system. EMBO J (1987) 0.82
Epidermal growth factor stimulates tyrosine phosphorylation of human glucocorticoid receptor in cultured cells. Biochem Biophys Res Commun (1987) 0.80
A 67 kDa non-hormone binding estradiol receptor is present in human mammary cancers. Int J Cancer (1996) 0.77
A signature motif in transcriptional co-activators mediates binding to nuclear receptors. Nature (1997) 11.15
A modified oestrogen receptor ligand-binding domain as an improved switch for the regulation of heterologous proteins. Nucleic Acids Res (1995) 7.95
Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay. Mol Endocrinol (1997) 4.71
Identification of a conserved region required for hormone dependent transcriptional activation by steroid hormone receptors. EMBO J (1992) 4.69
Nuclear factor RIP140 modulates transcriptional activation by the estrogen receptor. EMBO J (1995) 4.23
Environmentally persistent alkylphenolic compounds are estrogenic. Endocrinology (1994) 4.10
A variety of environmentally persistent chemicals, including some phthalate plasticizers, are weakly estrogenic. Environ Health Perspect (1995) 3.47
Characterization and colocalization of steroid binding and dimerization activities in the mouse estrogen receptor. Cell (1990) 3.37
Interaction of proteins with transcriptionally active estrogen receptors. Proc Natl Acad Sci U S A (1994) 3.10
Docosahexaenoic acid, a ligand for the retinoid X receptor in mouse brain. Science (2000) 2.90
HER-2 tyrosine kinase pathway targets estrogen receptor and promotes hormone-independent growth in human breast cancer cells. Oncogene (1995) 2.84
Identification of two transactivation domains in the mouse oestrogen receptor. Nucleic Acids Res (1989) 2.70
Human estrogen receptor transactivational capacity is determined by both cellular and promoter context and mediated by two functionally distinct intramolecular regions. Mol Endocrinol (1994) 2.62
Isoforms of steroid receptor co-activator 1 differ in their ability to potentiate transcription by the oestrogen receptor. EMBO J (1998) 2.44
Estrogen receptors alpha and beta form heterodimers on DNA. J Biol Chem (1997) 2.39
Identification of residues in the estrogen receptor that confer differential sensitivity to estrogen and hydroxytamoxifen. Mol Endocrinol (1993) 2.37
Effect of hypnotherapy and educational intervention on brain response to visceral stimulus in the irritable bowel syndrome. Aliment Pharmacol Ther (2013) 2.26
Semliki Forest virus expression system: production of conditionally infectious recombinant particles. Biotechnology (N Y) (1993) 2.20
The antiestrogen ICI 182780 disrupts estrogen receptor nucleocytoplasmic shuttling. J Cell Sci (1993) 2.04
Inhibition of estrogen receptor-DNA binding by the "pure" antiestrogen ICI 164,384 appears to be mediated by impaired receptor dimerization. Proc Natl Acad Sci U S A (1990) 2.03
17beta-Estradiol induces cyclin D1 gene transcription, p36D1-p34cdk4 complex activation and p105Rb phosphorylation during mitogenic stimulation of G(1)-arrested human breast cancer cells. Oncogene (1996) 2.01
The AF1 and AF2 domains of the androgen receptor interact with distinct regions of SRC1. Mol Cell Biol (1999) 2.00
Antiestrogen ICI 164,384 reduces cellular estrogen receptor content by increasing its turnover. Proc Natl Acad Sci U S A (1992) 1.96
The estrogenic activity of phthalate esters in vitro. Environ Health Perspect (1997) 1.94
Contrasting developmental and tissue-specific expression of alpha and beta thyroid hormone receptor genes. EMBO J (1990) 1.79
Transcriptional activators differ in their responses to overexpression of TATA-box-binding protein. Mol Cell Biol (1995) 1.77
Use of a purified outer membrane protein F (porin) preparation of Pseudomonas aeruginosa as a protective vaccine in mice. Infect Immun (1984) 1.75
Peptide growth factors elicit estrogen receptor-dependent transcriptional activation of an estrogen-responsive element. Mol Endocrinol (1993) 1.72
Reduction mammaplasty: an outcome analysis. Ann Plast Surg (1995) 1.62
Identification of novel oestrogen receptor target genes in human ZR75-1 breast cancer cells by expression profiling. J Mol Endocrinol (2001) 1.59
Functional interaction between the p160 coactivator proteins and the transcriptional enhancer factor family of transcription factors. J Biol Chem (2000) 1.59
A consensus DNA-binding site for the androgen receptor. Mol Endocrinol (1992) 1.59
AF-2 activity and recruitment of steroid receptor coactivator 1 to the estrogen receptor depend on a lysine residue conserved in nuclear receptors. Mol Cell Biol (1997) 1.58
Differential effects of xenoestrogens on coactivator recruitment by estrogen receptor (ER) alpha and ERbeta. J Biol Chem (2000) 1.54
Molecular determinants of the estrogen receptor-coactivator interface. Mol Cell Biol (1999) 1.46
RIP-140 interacts with multiple nuclear receptors by means of two distinct sites. Mol Cell Biol (1996) 1.39
Regulation of gene expression by nuclear hormone receptors. Curr Opin Cell Biol (1989) 1.37
Rat prostatic steroid binding protein: DNA sequence and transcript maps of the two C3 genes. EMBO J (1983) 1.35
An outcomes analysis and satisfaction survey of 199 consecutive abdominoplasties. Ann Plast Surg (2001) 1.33
A comparison of transcriptional activation by ER alpha and ER beta. J Steroid Biochem Mol Biol (1999) 1.31
Core LXXLL motif sequences in CREB-binding protein, SRC1, and RIP140 define affinity and selectivity for steroid and retinoid receptors. J Biol Chem (2000) 1.29
Crouzon syndrome: mutations in two spliceoforms of FGFR2 and a common point mutation shared with Jackson-Weiss syndrome. Hum Mol Genet (1995) 1.25
Mutations in the estrogen receptor ligand binding domain discriminate between hormone-dependent transactivation and transrepression. J Biol Chem (2000) 1.22
Binding characteristics of the thyroid hormone receptor homo- and heterodimers to consensus AGGTCA repeat motifs. Mol Endocrinol (1992) 1.21
Evidence for oestrogen receptor alpha-immunoreactivity in gonadotrophin-releasing hormone-expressing neurones. J Neuroendocrinol (1999) 1.20
Specific mutations in the estrogen receptor change the properties of antiestrogens to full agonists. Proc Natl Acad Sci U S A (1995) 1.19
Cofactor competition between the ligand-bound oestrogen receptor and an intron 1 enhancer leads to oestrogen repression of ERBB2 expression in breast cancer. Oncogene (2000) 1.18
A secretory protease inhibitor requires androgens for its expression in male sex accessory tissues but is expressed constitutively in pancreas. EMBO J (1987) 1.18
Effects of androgens on the complexity of poly(A) RNA from rat prostate. Cell (1977) 1.17
Hormonal regulation of protein synthesis in the rat epididymis. Characterization of androgen-dependent and testicular fluid-dependent proteins. Biochem J (1980) 1.16
The first step: activation of the Semliki Forest virus spike protein precursor causes a localized conformational change in the trimeric spike. J Mol Biol (1998) 1.16
Evidence for extensive distribution of oestrogen receptor alpha-immunoreactivity in the cerebral cortex of adult rats. J Neuroendocrinol (1999) 1.15
Testosterone regulates the synthesis of major proteins in rat ventral prostate. Biochem J (1978) 1.14
Prostatic steroid-binding protein. Isolation and characterization of C3 genes. J Biol Chem (1983) 1.12
Androgen-regulated expression of a cloned rat prostatic c3 gene transfected into mouse mammary tumor cells. Cell (1983) 1.12
A 22-amino-acid peptide restores DNA-binding activity to dimerization-defective mutants of the estrogen receptor. Mol Cell Biol (1990) 1.11
A natural transactivation mutation in the thyroid hormone beta receptor: impaired interaction with putative transcriptional mediators. Proc Natl Acad Sci U S A (1997) 1.10
Cloning and characterization of androgen-dependent mRNA from rat ventral prostate. J Biol Chem (1980) 1.09
A specific lysine in c-Jun is required for transcriptional repression by E1A and is acetylated by p300. EMBO J (2001) 1.09
Nuclear receptors spring into action. Nat Struct Biol (1996) 1.08
Distinct domains of the RelA NF-kappaB subunit are required for negative cross-talk and direct interaction with the glucocorticoid receptor. J Biol Chem (1997) 1.07
Mechanism of estrogen receptor-dependent transcription in a cell-free system. Mol Cell Biol (1990) 1.07
Peptide growth factor cross-talk with the estrogen receptor requires the A/B domain and occurs independently of protein kinase C or estradiol. Endocrinology (1996) 1.06
Socioeconomic status, marital status and hip fracture risk: a population-based case-control study. Osteoporos Int (2000) 1.04
Mechanisms of androgen receptor activation in advanced prostate cancer: differential co-activator recruitment and gene expression. Oncogene (2007) 1.04
Blood gases and acid-base values of unanesthetized rats exposed to hypoxia. Am J Physiol (1967) 1.04
CAAT/enhancer binding protein is able to bind to ATF/CRE elements. Nucleic Acids Res (1991) 1.02
Steroid receptor coactivator-1 splice variants differentially affect corticosteroid receptor signaling. Endocrinology (2004) 1.01
Effects of testosterone on sequence complexity of polyadenylated RNA from rat seminal vesicle. Eur J Biochem (1978) 1.01
Malignancy and chronic wounds: Marjolin's ulcer. J Burn Care Rehabil (1991) 1.00
Characterization of ligand-dependent phosphorylation of the estrogen receptor. Mol Endocrinol (1994) 1.00
Functional estrogen receptors in osteoblastic cells demonstrated by transfection with a reporter gene containing an estrogen response element. Mol Endocrinol (1991) 0.99
1,4-Bis[2-(3,5-dichloropyridyloxy)]benzene, an extremely potent modulator of mouse hepatic cytochrome P-450 gene expression. Biochem J (1993) 0.98
The prevalence of pain among the oldest old in Sweden. Pain (1996) 0.97
COUP-TF II homodimers are formed in preference to heterodimers with RXR alpha or TR beta in intact cells. Nucleic Acids Res (1995) 0.96
Mechanical strain and estrogen activate estrogen receptor alpha in bone cells. J Bone Miner Res (2001) 0.96
Interplay between estrogens, progestins, retinoic acid and AP-1 on a single regulatory site in the progesterone receptor gene. J Biol Chem (1994) 0.96
Regulation of prostatic steroid binding protein mRNAs by testosterone. Mol Cell Endocrinol (1985) 0.96
The androgenic regulation of abundant mRNA in rat ventral prostate. Eur J Biochem (1978) 0.96
The mouse homeobox gene, S8, is expressed during embryogenesis predominantly in mesenchyme. Mech Dev (1991) 0.95
Cross-talk between Stat5b and estrogen receptor-alpha and -beta in mammary epithelial cells. J Mol Endocrinol (2001) 0.94
Systemic inflammation in childhood obesity: circulating inflammatory mediators and activated CD14++ monocytes. Diabetologia (2012) 0.94
Mobility limitations in the Swedish population from 1968 to 1992: age, gender and social class differences. Aging (Milano) (2000) 0.94
Tissue-specific and hormonal regulation of the gene for rat prostatic steroid-binding protein in transgenic mice. Mol Cell Biol (1989) 0.93
Androgen-regulated expression of secretory protein synthesis in mouse ventral prostate. Mol Cell Endocrinol (1987) 0.93
Analysis of the aromatase cytochrome P450 gene in human breast cancers. J Mol Endocrinol (1994) 0.93
Effect of androgen on the transcription of rat prostatic binding protein genes. Mol Cell Endocrinol (1982) 0.93
Androgenic regulation of messenger RNA in rat epididymis. Biochem J (1980) 0.92
Altered plasma adipokine levels and in vitro adipocyte differentiation in pediatric type 1 diabetes. J Clin Endocrinol Metab (2011) 0.92
Priorities in care and services for elderly people: a path without guidelines? J Med Ethics (2000) 0.92
Characterisation of non-obese diabetic patients with marked insulin resistance identifies a novel familial partial lipodystrophy-associated PPARγ mutation (Y151C). Diabetologia (2011) 0.90
Adipose tissue dysfunction and hypertriglyceridemia: mechanisms and management. Obes Rev (2011) 0.90
Identification of phosphorylation sites in the mouse oestrogen receptor. J Steroid Biochem Mol Biol (1995) 0.89